Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-kappa B/Bcl-2 pathway

导出原文传递

翻译打印收藏纠错

作者： Qian, Chunfa ^[1] ; Li, Ping ^[2] ; Yan, Wei ^[3] ; Shi, Lei ^[4] ; Zhang, Junxia ; Wang, Yingyi ; Liu, Hongyi ; You, Yongping

作者单位： Anhui Med Univ, Dept Neurosurg, Hosp 2, Hefei 230601, Anhui, Peoples R China ^[1] Nanjing Med Univ, Dept Neurosurg, Nanjing Brain Hosp, Nanjing 210029, Jiangsu, Peoples R China ^[2] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou 215300, Jiangsu, Peoples R China ^[3] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China ^[4]

关键词 glioma osteopontin chemotherapy NF-kappa B/Bcl-2

发布时间 2016-01-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular medicine reports

2015年11卷3期

1951-1955页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-kappa B/Bcl-2 pathway

Molecular medicine reports

相似文献

Molecular medicine reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-kappa B/Bcl-2 pathway

Molecular medicine reports

相似文献

Molecular medicine reports

相关期刊

检索历史清除